Quick Stack Summary
| Semax | Selank | |
|---|---|---|
| Parent structure | Synthetic ACTH(4-10) analog | Synthetic tuftsin analog |
| Primary association | Focus, cognition, neuroprotection | Reduced anxiety without sedation |
| Proposed mechanisms | BDNF expression, dopaminergic and serotonergic modulation | GABAergic signaling, enkephalin-degrading enzyme inhibition, some BDNF influence |
| Russian clinical history | Nasal spray, stroke recovery and cognitive impairment | Nasal drops |
| Combined-arm trial | None identified | |
Why These Two Are Often Combined
Semax is generally associated with mental focus and cognitive sharpness, while Selank is generally associated with calm and reduced anxiety without the sedation that typically comes with anti-anxiety approaches. The appeal of stacking them is getting both effects at once: clear-headed focus without anxious jitteriness, or calm without brain fog. For a closer look at how the two compare head to head, see Semax vs Selank.
Extrapolation, not a tested combination: this rationale is built from each compound's separate, individually reported effects, not from a demonstrated combined outcome in a controlled trial. No published research has specifically studied Semax and Selank administered together. As with other stacks on this site, the case for pairing them rests on separate compound research, not a dedicated combined-arm study, and that distinction is worth keeping in mind before treating the pairing as more established than it is.
Semax's Role
Semax is a synthetic peptide analog of ACTH(4-10), studied mainly for cognitive enhancement, focus, and neuroprotection. Proposed mechanisms include increased BDNF expression and modulation of dopaminergic and serotonergic systems. It has a documented history of clinical and medical use in Russia, administered as a nasal spray in contexts including stroke recovery and cognitive impairment.
Selank's Role
Selank is a synthetic analog of tuftsin, studied mainly for anxiolytic effects without sedation, along with some immune-modulating research. Proposed mechanisms include effects on GABAergic signaling, inhibition of enkephalin-degrading enzymes, and some influence on BDNF expression. Like Semax, it has a documented Russian clinical and registration history, administered as nasal drops.
Timing and Practical Notes
Because Semax and Selank are both typically administered intranasally in the same dosing windows people already use for each compound on its own, they are often taken together or staggered by a few minutes rather than requiring a separate schedule. Some people report using Semax earlier in the day for focus and reserving Selank for periods when anxiety or stress is more likely to interfere with concentration. This is a matter of individual pattern and preference rather than a protocol validated by research on the combination, and there is no published dosing schedule specific to running them together.
Safety Considerations
Neither Semax nor Selank is FDA-approved. In July 2026 an FDA advisory committee voted in favor of adding Semax to the 503A compounding list, but that vote is nonbinding and Selank was not part of that review (AJMC). Both are still sold in the United States as research chemicals outside their historical Russian registration, which means neither carries the kind of large-scale, peer-reviewed human safety data that an approved medication would have. Combining two compounds means combining whatever individual safety unknowns each one carries, not just their intended effects, and that is true here even though both compounds are generally described as well tolerated individually. For what's actually been shown for each compound in humans, see the evidence reviews for Semax and Selank.
A Note on Bloodwork
Neither Semax nor Selank has a standard clinical marker tied to its mechanism, so there is no single blood test that shows whether either compound is doing what it is intended to do. A general safety baseline, a comprehensive metabolic panel and a CBC, is a reasonable starting point before running any peptide protocol, not because either compound is known to move those markers, but as ordinary due diligence before starting something new.
Related Reading
For the mechanism comparison behind this stack, see Semax vs Selank. For what's actually been studied in humans versus animals, see the evidence reviews for Semax and Selank. BioStackIQ's Rate My Stack and Build Protocol can help plan timing once a direction is chosen.
Frequently Asked Questions
Why are Semax and Selank stacked together?
Semax is generally associated with mental focus and cognitive sharpness, while Selank is generally associated with reduced anxiety without sedation. The appeal of combining them is getting both effects at once, clear-headed focus without anxious jitteriness, or calm without brain fog. This is a rationale built from each compound's separate, individually reported effects, not a demonstrated combined outcome.
Is there research on the Semax and Selank combination specifically?
No published research has specifically studied Semax and Selank administered together. The rationale for stacking them rests on separate research into each compound's mechanism, not on a dedicated combined-arm study. That distinction matters, because it means the specific claim of an added benefit from combining them has not been tested in any controlled trial.
How does the Russia versus Western evidence gap apply to this stack?
Both Semax and Selank individually have more clinical and registration history in Russia than peer-reviewed trial data in Western research settings, a caveat covered in depth on each compound's evidence review page. Since no combined study of the two exists at all, that visibility gap applies doubly to this stack. Even less is known about the pairing specifically than about either compound alone in a Western research context.
What is the practical difference between how Semax and Selank are described?
Semax is studied mainly for cognitive enhancement, focus, and neuroprotection, with proposed mechanisms including increased BDNF expression and modulation of dopaminergic and serotonergic systems. Selank is studied mainly for anxiolytic effects without sedation, along with some immune-modulating research, with proposed mechanisms including GABAergic signaling, inhibition of enkephalin-degrading enzymes, and some influence on BDNF expression.
What bloodwork should be tracked with this stack?
Neither Semax nor Selank has a standard clinical marker tied to its mechanism, so there is no single blood test that shows whether either compound is doing what it is intended to do. A general safety baseline, a comprehensive metabolic panel and a CBC, is a reasonable starting point before running any peptide protocol, not because either compound is known to move those markers, but as ordinary due diligence.